Who owns Edwards Lifesciences (EW)? Superinvestor holders
9 superinvestors of the 157 tracked here hold Edwards Lifesciences (EW) in their latest 13F filing, with $2.3B between them. David Rolfe gives it the most weight: 3.09% of the reported portfolio. In their latest reported quarter, Brandon Haley, Israel Englander, Ken Griffin and Primecap team and 2 more added; David Rolfe, Howard Gleicher and Steve Cohen reduced.
Andreas Halvorsen sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 9 of 157
- Biggest holder
- Howard Gleicher, $700.7M
- Largest weight
- David Rolfe, 3.09%of their portfolio
- Combined value
- $2.3B
- Bought last quarter
- 6
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | David RolfeWedgewood Partners | 3.09% | $14.9M | 165.21K | ▼ Reduced 3.4% | −5.76K | Q2 2026 |
| 2 | Howard GleicherAristotle Capital Management | 1.60% | $700.7M | 8.12M | ▼ Reduced 6.3% | −547.64K | Q3 2026 |
| 3 | Brandon HaleyHolocene Advisors | 0.65% | $284M | 3.14M | ▲ Added 325% | +2.4M | Q2 2026 |
| 4 | Steve CohenPoint72 Asset Management | 0.25% | $160.5M | 1.77M | ▼ Reduced 2.9% | −52.42K | Q2 2026 |
| 5 | Israel EnglanderMillennium Management | 0.22% | $324.3M | 3.58M | ▲ Added 100% | +1.79M | Q2 2026 |
| 6 | Ken GriffinCitadel Advisors | 0.21% | $361.7M | 4M | ▲ Added 670% | +3.48M | Q2 2026 |
| 7 | Primecap teamPrimecap Management | 0.19% | $309.4M | 3.58M | ▲ Added 5.2% | +175.53K | Q3 2026 |
| 8 | Baillie Gifford teamBaillie Gifford & Co | 0.14% | $150.2M | 1.74M | ▲ Added 44% | +531.58K | Q3 2026 |
| 9 | Ron BaronBaron Capital (BAMCO) | 0.06% | $38.5M | 445.88K | ▲ Added 94% | +216.27K | Q3 2026 |
Sold out last quarter
- Andreas Halvorsenwas $87.9M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 4 | 13.89M | $1.2B | 3 | 1 |
| Q2 2026 | 157 | 8 | 25.94M | $2.3B | 5 | 4 |
| Q1 2026 | 157 | 4 | 6.52M | $522M | 3 | 1 |
| Q4 2025 | 157 | 4 | 11.93M | $1B | 1 | 4 |
| Q3 2025 | 157 | 5 | 15.76M | $1.2B | 4 | 3 |
| Q2 2025 | 157 | 7 | 31.23M | $2.4B | 5 | 4 |
| Q1 2025 | 156 | 9 | 34.97M | $2.5B | 7 | 6 |
| Q4 2024 | 156 | 11 | 25.45M | $1.9B | 6 | 7 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Howard Gleicher | 8.12M | 8.67M | — | — | — | — | — | — |
| Primecap team | 3.58M | 3.41M | 3.42M | 3.42M | 3.52M | 3.45M | 2.3M | 2.04M |
| Baillie Gifford team | 1.74M | 1.21M | — | — | — | — | 581.44K | 706.8K |
| Ron Baron | 445.88K | — | — | — | — | — | — | — |
| Ken Griffin | · | 4M | — | — | 4.23M | 12.73M | 13.38M | 9.42M |
| Israel Englander | · | 3.58M | — | 6.08M | — | 6.68M | 3.44M | — |
| Brandon Haley | · | 3.14M | — | 2.25M | 4.75M | 4.7M | 3.48M | 2.41M |
| Steve Cohen | · | 1.77M | 1.83M | — | — | 3.04M | 1.47M | — |
| David Rolfe | · | 165.21K | 170.97K | 180.88K | 184.7K | 178.03K | 191.82K | 339.44K |
| Andreas Halvorsen | · | — | 1.1M | — | 3.07M | — | — | — |
| Ray Dalio (founder) | · | — | — | — | — | 444.92K | — | — |
| Ken Fisher | — | — | — | — | — | — | 10.1M | 9.78M |
| Frank Sands | — | — | — | — | — | — | 19.24K | 18.07K |
| Doug Silverman | — | — | — | — | — | — | — | 490K |
| George Soros | — | — | — | — | — | — | — | 250K |
| Andrew Spokes | — | — | — | — | — | — | — | 3K |
| François Rochon | — | — | — | — | — | — | — | 257 |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own EW?
In their latest 13F filings: David Rolfe (3.09% of the portfolio, $14.9M), Howard Gleicher (1.60% of the portfolio, $700.7M), Brandon Haley (0.65% of the portfolio, $284M), Steve Cohen (0.25% of the portfolio, $160.5M), Israel Englander (0.22% of the portfolio, $324.3M), Ken Griffin (0.21% of the portfolio, $361.7M), Primecap team (0.19% of the portfolio, $309.4M), Baillie Gifford team (0.14% of the portfolio, $150.2M), and 1 more.
Who bought EW last quarter?
Brandon Haley (added 325%), Israel Englander (added 100%), Ken Griffin (added 670%), Primecap team (added 5.2%), Baillie Gifford team (added 44%), Ron Baron (added 94%). “Last quarter” is each investor's latest reported quarter.
Who sold EW last quarter?
Reduced: David Rolfe (3.4% fewer shares), Howard Gleicher (6.3% fewer shares), Steve Cohen (2.9% fewer shares). Sold out entirely: Andreas Halvorsen (was $87.9M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Edwards Lifesciences (EW)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/EW/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to EW by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.